Author

Vanesa Santos

Spanish National Cancer Research CentreORCID 0009-0007-9563-379XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Eduardo J. CaleirasiD· 2 shared Héctor PeinadoiD· 2 shared Juan García-AgullóiD· 2 shared Blanca MajemiD· 1 shared Carmen Blanco‐AparicioiD· 1 shared Catalina Berca· 1 shared Daniel Achuela· 1 shared Elena AndradaiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Eduardo J. CaleirasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 25, 2026

NGFR-driven suppression of antigen presentation limits CD8+ T cell immunity and response to checkpoint blockade

Juan García-Agulló, Vanesa Santos, Blanca Majem…·Héctor Peinado

This study identifies NGFR as a regulator of immune evasion in HNSCC, showing that its inhibition enhances antigen presentation and CD8+ T cell response to checkpoint blockade.

DOI 10.64898/2026.08.24.746602

mousehuman

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 18, 2026

Nerve growth factor receptor identifies a basal subpopulation linked to poor prognosis and reduced immunotherapy responses in bladder cancer

Juan García-Agulló, Vanesa Santos, Mark Kalisz…·Héctor Peinado

This study identifies NGFR as a marker of a basal BLCA subpopulation associated with poor prognosis and reduced immunotherapy response.

DOI 10.64898/2026.05.14.725085

humanbulk RNA-seq

𝕏 PostBluesky